世界の低分子創薬市場の成長(現状と展望)2024-2030年Global Small-Molecule Drug Discovery Market Growth (Status and Outlook) 2024-2030 世界の低分子創薬市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%と予測されています。 LPI(エルピーアイ情報)の最新調査レポート「... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー世界の低分子創薬市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%と予測されています。LPI(エルピーアイ情報)の最新調査レポート「低分子創薬産業予測」は、2023年の世界の低分子創薬売上高を過去の売上高と合計し、2024年から2030年までの低分子創薬売上高予測を地域別・市場分野別に包括的に分析しています。地域別、市場分野別、サブセクター別に分けた低分子創薬売上高で、世界の低分子創薬産業の詳細な分析を百万米ドル単位で提供します。 本インサイトレポートでは、世界の低分子創薬の状況を包括的に分析し、製品区分、企業設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、本レポートでは、加速する世界の低分子創薬市場における各企業の独自のポジションをより深く理解するために、低分子創薬のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析しています。 本インサイトレポートでは、低分子創薬の世界的な見通しを形成している主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に分類して予測を行い、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づく透明性の高い手法により、本調査予測は世界の低分子創薬の現状と将来の軌道について非常にニュアンスの異なる見解を提供します。 世界の医薬品市場は2022年に1,475億ドルに達し、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調しています。 本レポートでは、低分子創薬市場の包括的な概要、市場シェア、成長機会を、製品タイプ別、用途別、主要企業別、主要地域・国別に紹介する。 タイプ別セグメント 錠剤 錠剤 その他 用途別セグメント がん領域 循環器 皮膚科学 中枢神経系 呼吸器 消化器 その他 本レポートではまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ファイザー メルク ブリストル・マイヤーズ スクイブ グラクソ・スミスクライン ベーリンガーインゲルハイム アストラゼネカ ジョンソン・エンド・ジョンソン テバ・ファーマシューティカルズ ギリアド・サイエンシズ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Small-Molecule Drug Discovery Market Size 2019-2030 2.1.2 Small-Molecule Drug Discovery Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Small-Molecule Drug Discovery Segment by Type 2.2.1 Pills 2.2.2 Tablets 2.2.3 Others 2.3 Small-Molecule Drug Discovery Market Size by Type 2.3.1 Small-Molecule Drug Discovery Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Small-Molecule Drug Discovery Market Size Market Share by Type (2019-2024) 2.4 Small-Molecule Drug Discovery Segment by Application 2.4.1 Oncology 2.4.2 Cardiovascular 2.4.3 Dermatology 2.4.4 Central Nervous System 2.4.5 Respiratory 2.4.6 Gastrointestinal 2.4.7 Others 2.5 Small-Molecule Drug Discovery Market Size by Application 2.5.1 Small-Molecule Drug Discovery Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Small-Molecule Drug Discovery Market Size Market Share by Application (2019-2024) 3 Small-Molecule Drug Discovery Market Size by Player 3.1 Small-Molecule Drug Discovery Market Size Market Share by Players 3.1.1 Global Small-Molecule Drug Discovery Revenue by Players (2019-2024) 3.1.2 Global Small-Molecule Drug Discovery Revenue Market Share by Players (2019-2024) 3.2 Global Small-Molecule Drug Discovery Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Small-Molecule Drug Discovery by Regions 4.1 Small-Molecule Drug Discovery Market Size by Regions (2019-2024) 4.2 Americas Small-Molecule Drug Discovery Market Size Growth (2019-2024) 4.3 APAC Small-Molecule Drug Discovery Market Size Growth (2019-2024) 4.4 Europe Small-Molecule Drug Discovery Market Size Growth (2019-2024) 4.5 Middle East & Africa Small-Molecule Drug Discovery Market Size Growth (2019-2024) 5 Americas 5.1 Americas Small-Molecule Drug Discovery Market Size by Country (2019-2024) 5.2 Americas Small-Molecule Drug Discovery Market Size by Type (2019-2024) 5.3 Americas Small-Molecule Drug Discovery Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Small-Molecule Drug Discovery Market Size by Region (2019-2024) 6.2 APAC Small-Molecule Drug Discovery Market Size by Type (2019-2024) 6.3 APAC Small-Molecule Drug Discovery Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Small-Molecule Drug Discovery by Country (2019-2024) 7.2 Europe Small-Molecule Drug Discovery Market Size by Type (2019-2024) 7.3 Europe Small-Molecule Drug Discovery Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Small-Molecule Drug Discovery by Region (2019-2024) 8.2 Middle East & Africa Small-Molecule Drug Discovery Market Size by Type (2019-2024) 8.3 Middle East & Africa Small-Molecule Drug Discovery Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Small-Molecule Drug Discovery Market Forecast 10.1 Global Small-Molecule Drug Discovery Forecast by Regions (2025-2030) 10.1.1 Global Small-Molecule Drug Discovery Forecast by Regions (2025-2030) 10.1.2 Americas Small-Molecule Drug Discovery Forecast 10.1.3 APAC Small-Molecule Drug Discovery Forecast 10.1.4 Europe Small-Molecule Drug Discovery Forecast 10.1.5 Middle East & Africa Small-Molecule Drug Discovery Forecast 10.2 Americas Small-Molecule Drug Discovery Forecast by Country (2025-2030) 10.2.1 United States Small-Molecule Drug Discovery Market Forecast 10.2.2 Canada Small-Molecule Drug Discovery Market Forecast 10.2.3 Mexico Small-Molecule Drug Discovery Market Forecast 10.2.4 Brazil Small-Molecule Drug Discovery Market Forecast 10.3 APAC Small-Molecule Drug Discovery Forecast by Region (2025-2030) 10.3.1 China Small-Molecule Drug Discovery Market Forecast 10.3.2 Japan Small-Molecule Drug Discovery Market Forecast 10.3.3 Korea Small-Molecule Drug Discovery Market Forecast 10.3.4 Southeast Asia Small-Molecule Drug Discovery Market Forecast 10.3.5 India Small-Molecule Drug Discovery Market Forecast 10.3.6 Australia Small-Molecule Drug Discovery Market Forecast 10.4 Europe Small-Molecule Drug Discovery Forecast by Country (2025-2030) 10.4.1 Germany Small-Molecule Drug Discovery Market Forecast 10.4.2 France Small-Molecule Drug Discovery Market Forecast 10.4.3 UK Small-Molecule Drug Discovery Market Forecast 10.4.4 Italy Small-Molecule Drug Discovery Market Forecast 10.4.5 Russia Small-Molecule Drug Discovery Market Forecast 10.5 Middle East & Africa Small-Molecule Drug Discovery Forecast by Region (2025-2030) 10.5.1 Egypt Small-Molecule Drug Discovery Market Forecast 10.5.2 South Africa Small-Molecule Drug Discovery Market Forecast 10.5.3 Israel Small-Molecule Drug Discovery Market Forecast 10.5.4 Turkey Small-Molecule Drug Discovery Market Forecast 10.5.5 GCC Countries Small-Molecule Drug Discovery Market Forecast 10.6 Global Small-Molecule Drug Discovery Forecast by Type (2025-2030) 10.7 Global Small-Molecule Drug Discovery Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Pfizer 11.1.1 Pfizer Company Information 11.1.2 Pfizer Small-Molecule Drug Discovery Product Offered 11.1.3 Pfizer Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Pfizer Main Business Overview 11.1.5 Pfizer Latest Developments 11.2 Merck 11.2.1 Merck Company Information 11.2.2 Merck Small-Molecule Drug Discovery Product Offered 11.2.3 Merck Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Merck Main Business Overview 11.2.5 Merck Latest Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Information 11.3.2 Bristol-Myers Squibb Small-Molecule Drug Discovery Product Offered 11.3.3 Bristol-Myers Squibb Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Bristol-Myers Squibb Main Business Overview 11.3.5 Bristol-Myers Squibb Latest Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Information 11.4.2 GlaxoSmithKline Small-Molecule Drug Discovery Product Offered 11.4.3 GlaxoSmithKline Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 GlaxoSmithKline Main Business Overview 11.4.5 GlaxoSmithKline Latest Developments 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Company Information 11.5.2 Boehringer Ingelheim Small-Molecule Drug Discovery Product Offered 11.5.3 Boehringer Ingelheim Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Boehringer Ingelheim Main Business Overview 11.5.5 Boehringer Ingelheim Latest Developments 11.6 AstraZeneca 11.6.1 AstraZeneca Company Information 11.6.2 AstraZeneca Small-Molecule Drug Discovery Product Offered 11.6.3 AstraZeneca Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 AstraZeneca Main Business Overview 11.6.5 AstraZeneca Latest Developments 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Information 11.7.2 Johnson & Johnson Small-Molecule Drug Discovery Product Offered 11.7.3 Johnson & Johnson Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Johnson & Johnson Main Business Overview 11.7.5 Johnson & Johnson Latest Developments 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Company Information 11.8.2 Teva Pharmaceuticals Small-Molecule Drug Discovery Product Offered 11.8.3 Teva Pharmaceuticals Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Teva Pharmaceuticals Main Business Overview 11.8.5 Teva Pharmaceuticals Latest Developments 11.9 Gilead Sciences Inc. 11.9.1 Gilead Sciences Inc. Company Information 11.9.2 Gilead Sciences Inc. Small-Molecule Drug Discovery Product Offered 11.9.3 Gilead Sciences Inc. Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Gilead Sciences Inc. Main Business Overview 11.9.5 Gilead Sciences Inc. Latest Developments 12 Research Findings and Conclusion
SummaryThe global Small-Molecule Drug Discovery market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Small-Molecule Drug Discovery Market Size 2019-2030 2.1.2 Small-Molecule Drug Discovery Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Small-Molecule Drug Discovery Segment by Type 2.2.1 Pills 2.2.2 Tablets 2.2.3 Others 2.3 Small-Molecule Drug Discovery Market Size by Type 2.3.1 Small-Molecule Drug Discovery Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Small-Molecule Drug Discovery Market Size Market Share by Type (2019-2024) 2.4 Small-Molecule Drug Discovery Segment by Application 2.4.1 Oncology 2.4.2 Cardiovascular 2.4.3 Dermatology 2.4.4 Central Nervous System 2.4.5 Respiratory 2.4.6 Gastrointestinal 2.4.7 Others 2.5 Small-Molecule Drug Discovery Market Size by Application 2.5.1 Small-Molecule Drug Discovery Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Small-Molecule Drug Discovery Market Size Market Share by Application (2019-2024) 3 Small-Molecule Drug Discovery Market Size by Player 3.1 Small-Molecule Drug Discovery Market Size Market Share by Players 3.1.1 Global Small-Molecule Drug Discovery Revenue by Players (2019-2024) 3.1.2 Global Small-Molecule Drug Discovery Revenue Market Share by Players (2019-2024) 3.2 Global Small-Molecule Drug Discovery Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Small-Molecule Drug Discovery by Regions 4.1 Small-Molecule Drug Discovery Market Size by Regions (2019-2024) 4.2 Americas Small-Molecule Drug Discovery Market Size Growth (2019-2024) 4.3 APAC Small-Molecule Drug Discovery Market Size Growth (2019-2024) 4.4 Europe Small-Molecule Drug Discovery Market Size Growth (2019-2024) 4.5 Middle East & Africa Small-Molecule Drug Discovery Market Size Growth (2019-2024) 5 Americas 5.1 Americas Small-Molecule Drug Discovery Market Size by Country (2019-2024) 5.2 Americas Small-Molecule Drug Discovery Market Size by Type (2019-2024) 5.3 Americas Small-Molecule Drug Discovery Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Small-Molecule Drug Discovery Market Size by Region (2019-2024) 6.2 APAC Small-Molecule Drug Discovery Market Size by Type (2019-2024) 6.3 APAC Small-Molecule Drug Discovery Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Small-Molecule Drug Discovery by Country (2019-2024) 7.2 Europe Small-Molecule Drug Discovery Market Size by Type (2019-2024) 7.3 Europe Small-Molecule Drug Discovery Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Small-Molecule Drug Discovery by Region (2019-2024) 8.2 Middle East & Africa Small-Molecule Drug Discovery Market Size by Type (2019-2024) 8.3 Middle East & Africa Small-Molecule Drug Discovery Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Small-Molecule Drug Discovery Market Forecast 10.1 Global Small-Molecule Drug Discovery Forecast by Regions (2025-2030) 10.1.1 Global Small-Molecule Drug Discovery Forecast by Regions (2025-2030) 10.1.2 Americas Small-Molecule Drug Discovery Forecast 10.1.3 APAC Small-Molecule Drug Discovery Forecast 10.1.4 Europe Small-Molecule Drug Discovery Forecast 10.1.5 Middle East & Africa Small-Molecule Drug Discovery Forecast 10.2 Americas Small-Molecule Drug Discovery Forecast by Country (2025-2030) 10.2.1 United States Small-Molecule Drug Discovery Market Forecast 10.2.2 Canada Small-Molecule Drug Discovery Market Forecast 10.2.3 Mexico Small-Molecule Drug Discovery Market Forecast 10.2.4 Brazil Small-Molecule Drug Discovery Market Forecast 10.3 APAC Small-Molecule Drug Discovery Forecast by Region (2025-2030) 10.3.1 China Small-Molecule Drug Discovery Market Forecast 10.3.2 Japan Small-Molecule Drug Discovery Market Forecast 10.3.3 Korea Small-Molecule Drug Discovery Market Forecast 10.3.4 Southeast Asia Small-Molecule Drug Discovery Market Forecast 10.3.5 India Small-Molecule Drug Discovery Market Forecast 10.3.6 Australia Small-Molecule Drug Discovery Market Forecast 10.4 Europe Small-Molecule Drug Discovery Forecast by Country (2025-2030) 10.4.1 Germany Small-Molecule Drug Discovery Market Forecast 10.4.2 France Small-Molecule Drug Discovery Market Forecast 10.4.3 UK Small-Molecule Drug Discovery Market Forecast 10.4.4 Italy Small-Molecule Drug Discovery Market Forecast 10.4.5 Russia Small-Molecule Drug Discovery Market Forecast 10.5 Middle East & Africa Small-Molecule Drug Discovery Forecast by Region (2025-2030) 10.5.1 Egypt Small-Molecule Drug Discovery Market Forecast 10.5.2 South Africa Small-Molecule Drug Discovery Market Forecast 10.5.3 Israel Small-Molecule Drug Discovery Market Forecast 10.5.4 Turkey Small-Molecule Drug Discovery Market Forecast 10.5.5 GCC Countries Small-Molecule Drug Discovery Market Forecast 10.6 Global Small-Molecule Drug Discovery Forecast by Type (2025-2030) 10.7 Global Small-Molecule Drug Discovery Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Pfizer 11.1.1 Pfizer Company Information 11.1.2 Pfizer Small-Molecule Drug Discovery Product Offered 11.1.3 Pfizer Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Pfizer Main Business Overview 11.1.5 Pfizer Latest Developments 11.2 Merck 11.2.1 Merck Company Information 11.2.2 Merck Small-Molecule Drug Discovery Product Offered 11.2.3 Merck Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Merck Main Business Overview 11.2.5 Merck Latest Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Information 11.3.2 Bristol-Myers Squibb Small-Molecule Drug Discovery Product Offered 11.3.3 Bristol-Myers Squibb Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Bristol-Myers Squibb Main Business Overview 11.3.5 Bristol-Myers Squibb Latest Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Information 11.4.2 GlaxoSmithKline Small-Molecule Drug Discovery Product Offered 11.4.3 GlaxoSmithKline Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 GlaxoSmithKline Main Business Overview 11.4.5 GlaxoSmithKline Latest Developments 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Company Information 11.5.2 Boehringer Ingelheim Small-Molecule Drug Discovery Product Offered 11.5.3 Boehringer Ingelheim Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Boehringer Ingelheim Main Business Overview 11.5.5 Boehringer Ingelheim Latest Developments 11.6 AstraZeneca 11.6.1 AstraZeneca Company Information 11.6.2 AstraZeneca Small-Molecule Drug Discovery Product Offered 11.6.3 AstraZeneca Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 AstraZeneca Main Business Overview 11.6.5 AstraZeneca Latest Developments 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Information 11.7.2 Johnson & Johnson Small-Molecule Drug Discovery Product Offered 11.7.3 Johnson & Johnson Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Johnson & Johnson Main Business Overview 11.7.5 Johnson & Johnson Latest Developments 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Company Information 11.8.2 Teva Pharmaceuticals Small-Molecule Drug Discovery Product Offered 11.8.3 Teva Pharmaceuticals Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Teva Pharmaceuticals Main Business Overview 11.8.5 Teva Pharmaceuticals Latest Developments 11.9 Gilead Sciences Inc. 11.9.1 Gilead Sciences Inc. Company Information 11.9.2 Gilead Sciences Inc. Small-Molecule Drug Discovery Product Offered 11.9.3 Gilead Sciences Inc. Small-Molecule Drug Discovery Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Gilead Sciences Inc. Main Business Overview 11.9.5 Gilead Sciences Inc. Latest Developments 12 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD(drug)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|